Patents by Inventor V. S. Prasada Rao Lingam

V. S. Prasada Rao Lingam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fused pyrimidineone compounds as TRPV3 modulators
    Patent number: 8518955
    Abstract: The present invention provides transient receptor potential vanilloid (TRPV) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
    Type: Grant
    Filed: January 11, 2012
    Date of Patent: August 27, 2013
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: V. S. Prasada Rao Lingam, Sachin Sundarlal Chaudhari, Abraham Thomas, Neelima Khairatkar-Joshi, Vidya Ganpati Kattige
  • Chromane derivatives as TRPV3 modulators
    Patent number: 8492568
    Abstract: The present invention provides chromane derivatives as transient receptor potential vanilloid (TRPV) modulators. In particular, the compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: July 23, 2013
    Assignee: Glenmark Pharamceuticals S.A.
    Inventors: V. S. Prasada Rao Lingam, Abraham Thomas, Javed Yusuf Khatik, Neelima Khairatkar-Joshi, Vidya Ganapati Kattige
  • FUSED PYRIMIDINEONE COMPOUNDS AS TRPV3 MODULATORS
    Publication number: 20120115886
    Abstract: The present invention provides transient receptor potential vanilloid (TRPV) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
    Type: Application
    Filed: January 11, 2012
    Publication date: May 10, 2012
    Inventors: V. S. Prasada Rao LINGAM, Sachin Sundarial CHAUDHARI, Abraham THOMAS, Neelima KHAIRATKAR-JOSHI, Vidya Ganpati KATTIGE
  • Processes for the preparation of DPP IV inhibitors
    Patent number: 7893103
    Abstract: The present invention relates to novel processes for preparing DPP-IV inhibitors having the structure of formula I, and pharmaceutically acceptable salt thereof, which are useful for treatment of Type 2 diabetes.
    Type: Grant
    Filed: June 27, 2007
    Date of Patent: February 22, 2011
    Assignee: Glenmark Pharmaceuticals, S.A.
    Inventors: Abraham Thomas, V. S. Prasada Rao Lingam, Ashok Bhausaheb Kadam, Suresh M. Kadam, Shantaram Kashinath Phatangare, Deepak Vitthal Ukride
  • Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them
    Patent number: 7524844
    Abstract: The present invention relates to novel compounds useful as dipeptidyl peptidase IV (DPP-IV) inhibitors of the formula: wherein X, Y, a, R1, and R2 are as defined herein.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: April 28, 2009
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Abraham Thomas, Balasubramanian Gopalan, V.S. Prasada Rao Lingam, Daisy Manish Shah
  • ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS
    Publication number: 20080182851
    Abstract: The present invention provides Stearoyl CoA Desaturase (SCD) inhibitors. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by Stearoyl CoA Desaturase 1 (SCD1) inhibitors. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by Stearoyl CoA Desaturase (SCD) inhibitors.
    Type: Application
    Filed: November 19, 2007
    Publication date: July 31, 2008
    Applicant: Glenmark Pharmaceuticals S.A.
    Inventors: Abraham Thomas, V.S. Prasada Rao Lingam, Shantaram Kashinath Phatangare, Neelima Khairatkar-Joshi, Daisy Manish Shah, Deepak Vitthal Ukirde, Dattaguru Anandrao More
  • Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
    Patent number: 7230002
    Abstract: The present invention relates to novel dipeptidyl peptidase IV (DPP-IV) inhibitors their analogs, isomers, pharmaceutical compositions, therapeutic uses and methods of making the same.
    Type: Grant
    Filed: February 2, 2005
    Date of Patent: June 12, 2007
    Assignee: Glenmark Pharmaceuticals Ltd.
    Inventors: Abraham Thomas, Balasubramanian Gopalan, V. S. Prasada Rao Lingam, Daisy Manish Shah
  • Dipeptidyl peptidase IV inhibitors pharmaceutical compositions containing them, and process for their preparation
    Patent number: 7205323
    Abstract: The present invention relates to novel compounds useful as dipeptidyl peptidase IV (DPP-IV) inhibitors of the formula: wherein X, Y, a, R1, and R2 are as defined herein.
    Type: Grant
    Filed: October 12, 2005
    Date of Patent: April 17, 2007
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Abraham Thomas, Gopalan Balasubramanian, V. S. Prasada Rao Lingam, Daisy Manish Shah